Amarin Corporation PLC Announces the Addition of Industry Veteran Patrick O'Sullivan to Board

Published: Dec 14, 2011

BEDMINSTER, N.J. and DUBLIN, Ireland, Dec. 14, 2011 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Patrick "Paddy" O'Sullivan has joined the Board of Directors as an independent director effective December 13, 2011. Mr. O'Sullivan will also serve on the Audit Committee of the Board of Directors.

Back to news